Literature DB >> 7945767

Cytokine antagonists and their potential therapeutic use.

R Debets1, H F Savelkoul.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7945767     DOI： 10.1016/0167-5699(94)90187-2

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  6 in total

1.  A pharmacokinetic approach for evaluating cytokine binding macromolecules as antagonists.

Authors:  M Ramanathan
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

2.  Lithium and psoriasis: cytokine modulation of cultured lymphocytes and psoriatic keratinocytes by lithium.

Authors:  H M Ockenfels; S N Wagner; C Keim-Maas; R Funk; G Nussbaum; M Goos
Journal:  Arch Dermatol Res       Date:  1996-04       Impact factor: 3.017

3.  A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist.

Authors:  W Xu; S R Presnell; J Parrish-Novak; W Kindsvogel; S Jaspers; Z Chen; S R Dillon; Z Gao; T Gilbert; K Madden; S Schlutsmeyer; L Yao; T E Whitmore; Y Chandrasekher; F J Grant; M Maurer; L Jelinek; H Storey; T Brender; A Hammond; S Topouzis; C H Clegg; D C Foster
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

4.  Resonance assignments, secondary structure and topology of leukaemia inhibitory factor in solution.

Authors:  M G Hinds; T Maurer; J G Zhang; N A Nicola; R S Norton
Journal:  J Biomol NMR       Date:  1997-02       Impact factor: 2.835

5.  Effect of adjuvants on immunization with dengue virus-induced cytotoxic factor.

Authors:  R Mukerjee; U C Chaturvedi
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

6.  Cytokines as cellular communicators.

Authors:  R Debets; H F Savelkoul
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.